Perrigo And Allergan Announce First-To-Market Launch Of Store Brand OTC Equivalent To Mucinex(R) 1200mg ER Tablets

DUBLIN, March 23, 2016 -- (Healthcare Sales & Marketing Network) -- Perrigo Company (NYSE: PRGO; TASE) and its partner Allergan plc (AGN) today announced the launch of guaifenesin 1200mg extended-release tablets, the OTC store brand equivalent to Mucinex... Biopharmaceuticals, Product LaunchPerrigo Company, Allergan, guaifenesin, Mucinex
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news